NIM
TMO icon

Northeast Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Northeast Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.7M Sell
81,211
-481
-0.6% -$231K 1.5% 21
2026
Q1 		$40.2M Sell
81,692
-1,143
-1% -$620K 1.66% 19
2025
Q4 		$48M Sell
82,835
-579
-0.7% -$327K 1.88% 15
2025
Q3 		$40.5M Sell
83,414
-1,572
-2% -$732K 1.63% 17
2025
Q2 		$34.5M Sell
84,986
-974
-1% -$407K 1.47% 19
2025
Q1 		$42.8M Sell
85,960
-568
-0.7% -$308K 1.99% 15
2024
Q4 		$45M Sell
86,528
-268
-0.3% -$147K 2% 13
2024
Q3 		$53.7M Sell
86,796
-158
-0.2% -$93.5K 2.41% 10
2024
Q2 		$48.1M Sell
86,954
-468
-0.5% -$268K 2.26% 10
2024
Q1 		$50.8M Sell
87,422
-912
-1% -$512K 2.5% 9
2023
Q4 		$46.9M Sell
88,334
-669
-0.8% -$324K 2.51% 10
2023
Q3 		$45.1M Sell
89,003
-418
-0.5% -$223K 2.65% 9
2023
Q2 		$46.7M Sell
89,421
-1,985
-2% -$1.07M 2.63% 9
2023
Q1 		$52.7M Sell
91,406
-2,289
-2% -$1.29M 3.2% 6
2022
Q4 		$51.6M Sell
93,695
-1,820
-2% -$964K 3.29% 5
2022
Q3 		$48.4M Sell
95,515
-1,236
-1% -$692K 3.28% 8
2022
Q2 		$52.6M Sell
96,751
-1,975
-2% -$1.09M 3.35% 6
2022
Q1 		$58.3M Sell
98,726
-2,253
-2% -$1.29M 3.07% 8
2021
Q4 		$67.4M Sell
100,979
-2,464
-2% -$1.54M 3.29% 5
2021
Q3 		$59.1M Sell
103,443
-2,916
-3% -$1.6M 3.16% 8
2021
Q2 		$53.7M Sell
106,359
-3,415
-3% -$1.61M 2.89% 8
2021
Q1 		$50.1M Sell
109,774
-2,994
-3% -$1.43M 2.96% 8
2020
Q4 		$52.5M Sell
112,768
-4,531
-4% -$2.12M 3.2% 6
2020
Q3 		$51.8M Buy
117,299
+388
+0.3% +$160K 3.44% 5
2020
Q2 		$42.4M Buy
116,911
+330
+0.3% +$111K 3.17% 8
2020
Q1 		$33.1M Sell
116,581
-1,856
-2% -$585K 3.04% 7
2019
Q4 		$38.5M Sell
118,437
-1,291
-1% -$391K 2.83% 10
2019
Q3 		$34.9M Sell
119,728
-900
-0.7% -$258K 2.79% 9
2019
Q2 		$35.4M Sell
120,628
-651
-0.5% -$179K 2.81% 9
2019
Q1 		$33.2M Buy
121,279
+412
+0.3% +$103K 2.79% 8
2018
Q4 		$27M Sell
120,867
-1,757
-1% -$412K 2.6% 9
2018
Q3 		$29.9M Sell
122,624
-768
-0.6% -$177K 2.39% 11
2018
Q2 		$25.6M Buy
123,392
+2,833
+2% +$601K 2.16% 13
2018
Q1 		$24.9M Buy
120,559
+365
+0.3% +$76.6K 2.2% 13
2017
Q4 		$22.8M Buy
120,194
+4,457
+4% +$854K 1.92% 14
2017
Q3 		$21.9M Buy
115,737
+2,621
+2% +$475K 1.94% 15
2017
Q2 		$19.7M Buy
113,116
+10,369
+10% +$1.74M 1.8% 16
2017
Q1 		$15.8M Buy
102,747
+8,231
+9% +$1.26M 1.48% 27
2016
Q4 		$13.3M Buy
94,516
+8,735
+10% +$1.29M 1.28% 32
2016
Q3 		$13.6M Buy
85,781
+19,690
+30% +$3.03M 1.36% 30
2016
Q2 		$9.77M Buy
66,091
+28,837
+77% +$4.26M 0.98% 39
2016
Q1 		$5.28M Buy
37,254
+34,974
+1,534% +$4.69M 0.54% 56
2015
Q4 		$323K Sell
2,280
-226
-9% -$30.1K 0.03% 124
2015
Q3 		$306K Buy
+2,506
New +$326K 0.03% 130

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Northeast Investment Management's TMO Position: Q2 2026 in Review

Northeast Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 0.59% in Q2 2026, selling an estimated $231K and leaving 81,211 shares worth $40.7M. The position accounts for 1.5% of the portfolio, ranked #21.

Northeast Investment Management first reported a position in TMO in Q3 2015 and has held it in 44 quarters since. The position peaked at $67.4M in Q4 2021. 1,170 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Northeast Investment Management held 81,211 shares of Thermo Fisher Scientific worth $40.7M as of Q2 2026.
  • Northeast Investment Management sold 481 Thermo Fisher Scientific shares in Q2 2026, an estimated $231K.
  • Thermo Fisher Scientific made up 1.5% of Northeast Investment Management's portfolio in Q2 2026, its #21 holding.
  • Northeast Investment Management first reported a position in Thermo Fisher Scientific in Q3 2015 and has held it in 44 quarters since.
  • Northeast Investment Management's Thermo Fisher Scientific position peaked at $67.4M in Q4 2021.
  • 1,170 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Northeast Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.